Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women

OBJECTIVE:The objective of this study was to evaluate the efficacy and safety of three doses of estradiol gel 0.1% (Divigel, a novel formulation consisting of 1 mg estradiol per 1 g transdermal gel) to reduce the frequency and severity of vasomotor symptoms and signs of vulvar and vaginal atrophy as...

Full description

Saved in:

Bibliographic Details
Published in:	Menopause (New York, N.Y.) Vol. 16; no. 1; pp. 132 - 140
Main Authors:	Hedrick, Richard E., Ackerman, Ronald T., Koltun, William D., Halvorsen, Mark B., Lambrecht, Lawrence J.
Format:	Journal Article
Language:	English
Published:	United States The North American Menopause Society 01-01-2009
Subjects:	Administration, Cutaneous Adult Aged Atrophy Double-Blind Method Estradiol - administration & dosage Estradiol - adverse effects Estradiol - blood Estrone - blood Female Gels Hot Flashes - drug therapy Humans Middle Aged Patient Compliance Placebos Postmenopause Sweating Vagina - pathology Vasomotor System - physiology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!